Federal Data Hub › HRSA 340B · JSON
DELTA HEALTH CENTER, INC. · 340B ID CH040780
ParticipatingChildren's Hospital
DELTA HEALTH CENTER, INC. is a Children's Hospital enrolled in the federal 340B Drug Pricing Program in MOUND BAYOU, MS. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 20 contract-pharmacy arrangement(s) (14 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| AVITA PHARMACY 1037 | NEW ORLEANS, LA | 2018-10-01 | — | 889 |
| AVITA PHARMACY 1040 | BATON ROUGE, LA | 2018-10-01 | — | 1799 |
| AVITA PHARMACY 1043 | JACKSON, MS | 2020-01-01 | — | 123059 |
| KROGER FOOD AND DRUG 370 | CLEVELAND, MS | 2016-01-01 | 2022-01-05 | 46383 |
| LONGS DRUGS OF LEXINGTON | LEXINGTON, SC | 2018-10-01 | — | 91496 |
| MISSISSIPPI CVS PHARMACY, L.L.C. | GREENVILLE, MS | 2023-10-01 | — | 46364 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2023-10-01 | — | 70688 |
| WAL-MART PHARMACY 10-0182 | GREENVILLE, MS | 2016-07-01 | 2022-01-05 | 46367 |
| WAL-MART PHARMACY 10-0182 | GREENVILLE, MS | 2023-10-01 | — | 46367 |
| WAL-MART PHARMACY 10-0347 | INDIANOLA, MS | 2016-07-01 | 2022-01-05 | 46394 |
| WAL-MART PHARMACY 10-0347 | INDIANOLA, MS | 2023-10-01 | — | 46394 |
| WAL-MART PHARMACY 10-1530 | CLEVELAND, MS | 2016-01-01 | 2022-01-05 | 46384 |
| WAL-MART PHARMACY 10-1530 | CLEVELAND, MS | 2023-10-01 | — | 46384 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2023-10-01 | — | 39270 |
| WALGREEN CO. | CLEVELAND, MS | 2016-04-01 | 2022-01-06 | 3960 |
| WALGREEN CO. | CLEVELAND, MS | 2023-10-01 | — | 3960 |
| WALGREEN CO. | GREENVILLE, MS | 2016-04-01 | 2022-01-06 | 5113 |
| WALGREEN CO. | GREENVILLE, MS | 2023-10-01 | — | 5113 |
| WALMART PHARMACY 10-5169 | ROGERS, AR | 2023-10-01 | — | 66076 |
| Walmart Pharmacy 10-7611 | Plainfield, IN | 2024-07-01 | — | 140224 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.